July 2, 2024
Global Ultrasonic Nebulizer Market

The Global Ultrasonic Nebulizer Market Driven By Rising Prevalence Of Respiratory Diseases

Ultrasonic nebulizers provide an efficient pulmonary drug delivery mechanism by turning liquid medications into a mist and delivering it deep into the lungs, gaining significant traction among patients suffering from respiratory diseases. These devices help in treating severe breathing conditions like asthma, COPD, and cystic fibrosis through accurate dosing and quick absorption of medication by alveoli. Their use of ultrasound waves further ensures silent operation, making them suitable for both hospital and home care settings. The small droplet sizes produced by ultrasonic nebulizers are said to be optimal for targeting conditions affecting lower respiratory tracts efficiently.

The global Ultrasonic Nebulizer Market was valued at US$ 218.3 million in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by CoherentMI.

Market Key Trends:

The growing prevalence of respiratory diseases due to lifestyle changes and environmental pollution has significantly increased the demand for efficient pulmonary drug delivery devices like ultrasonic nebulizers. It is estimated that around 334 million people suffer from asthma worldwide while 65 million have COPD. Technological advancements enabling more accurate and controlled medication administration through hand-held, portables and mesh nebulizers are further boosting the ultrasonic nebulizer market growth. However, certain limitations around drug compatibility and high device costs pose challenges for market expansion.

Global Ultrasonic Nebulizer Market Segmentation

By Product Type

Large-volume ultrasonic nebulizers

Small-volume ultrasonic nebulizers

By Application

COPD

Cystic Fibrosis

Asthma

Others

By End User

Hospitals and Clinics

Emergency Centers

Home Healthcare

Others

By Region

North America

Latin America

Europe

Asia Pacific

Middle East

Africa

Porter’s Analysis

Threat of New Entrants: The threat of new entrants in the global ultrasonic nebulizer market is low. The market requires large capital investments and R&D expenses. It also has well-established industry players.

Bargaining Power of Buyers: The bargaining power of buyers is moderate. Buyers have many options available from various companies, which gives them better price negotiation power. However, switching costs for buyers are low.

Bargaining Power of Suppliers: The bargaining power of suppliers is moderate. Suppliers have a large number of raw material options. However, the materials used in ultrasonic nebulizers are standardized.

Threat of New Substitutes: The threat of substitutes is moderate. Alternatives include jet nebulizers, mesh nebulizers, and pressurized metered dose inhalers. However, ultrasonic nebulizers have better efficiency and portability.

Competitive Rivalry: The competition in the global ultrasonic nebulizer market is high due to the presence of many regional and international players. Companies compete based on product features, quality, pricing, and branding.

Key Takeaways

The Global Ultrasonic Nebulizer Market Size is expected to witness high growth. The global Ultrasonic Nebulizer Market was valued at US$ 218.3 million in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030.

North America region dominates the ultrasonic nebulizer market currently due to established healthcare facilities and high awareness levels. Asia Pacific is expected to witness the fastest growth during the forecast period owing to growing healthcare infrastructure, rising disposable incomes, and improving medical technologies adoption in countries like China and India.

Key Players operating in the ultrasonic nebulizer market are Philips Healthcare, Omron, PARI Medical, BD, Agilent Technologies, Airssential, Allied Healthcare Products, Briggs Healthcare, CareFusion, GF Health Products, Medline Industries, Medquip, DeVilbiss Healthcare, Medisana, Precision Medical, Rossmax, Salvatore Robuschi, Shenzhen Shenkang, VENTA-tec, and WalkMed. Philips Healthcare is one of the leading player in the ultrasonic nebulizer market with wide geographic presence in the industry.

Reasons to Purchase Global Ultrasonic Nebulizer Market Report:

1. Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation, and industry verticals.

2. Develop/modify business expansion plans by using substantial growth offerings in developed and emerging markets.

3. Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Global Ultrasonic Nebulizer Market.

FAQ’s

Q.1 What will the market development pace of the Global Ultrasonic Nebulizer Market?

Q.2 What are the sales, revenue, and price analysis of the top players of the Global Ultrasonic Nebulizer Market?

Q.3 What are the market opportunities and threats faced by the vendors in the Global Ultrasonic Nebulizer Market?

*Note:
1.       Source: CoherentMI, Public sources, Desk research
2.       We have leveraged AI tools to mine information and compile it